ABSTRACT Caspases, cystein proteases traditionally related to programmed cell death, have recently been found to be involved in vital processes such as cell proliferation, adhesion and differentiation. Although caspases are expressed in mouse embryos before the blastocyst stage, their role is unclear, since apoptosis does not occur significantly before implantation. In this work, we have used mouse preimplantation development as a model to evaluate the existence of nonlethal caspase activities. The use of specific caspase inhibitors during in vitro embryo culture showed that caspase 8 activity, but not caspase 2 or 9, was relevant for development. The inhibition of caspase 8 affected the compaction of morulae and the progression to the blastocyst stage. In agreement with these results, caspase 8 was expressed in mouse embryos, as shown by indirect immunofluorescence and RT-PCR. An in silico approach was used to find putative caspase targets expressed in mouse preimplantation embryos. Large-scale management of sequence data from mouse embryos was used to predict caspase substrates by tools matrix-based on known cleavage sites. A total of 510 potential caspase targets expressed in mouse embryos were identified by this procedure. The functional characterization of these proteins by Gene Onthology associations showed that many of these putative caspase targets were previously related to nonapoptotic functions and only 63 had been previously reported to be actually cleaved by caspases. Interestingly, eleven knockout mice models for caspase substrates identified in our work, i.e. catenin alpha and beta, geminin, pescadillo, calpain-2, have preimplantation lethal phenotypes. This work supports the involvement of caspases in vital functions during mouse preimplantation development and proposes a model in which the regulated cleavage of caspase substrates could account for this role.
Introduction
Caspases are members of a family of cysteine proteases that, once activated, cleave a variety of intracellular polypeptides. Although traditionally related to programmed cell death, recent evidence shows that there are many instances where caspases fail to promote apoptosis and instead play roles in various vital processes such as cell proliferation, motility and differentiation. In Drosophila melanogaster, caspases are involved in the removal of the cytoplasm of spermatids during their differentiation into sperm (Arama et al., 2003) . In mammals, the activity of caspases has also been related to the process of differentiation of numerous cell types such as myoblasts, megakaryocytes, lens cells, keratinocytes, monocytes, osteoblasts and colon cancer cells (Abraham et al., 2004; Launay et al., 2005) . As well, caspases have been shown to contribute to inflammation, lymphocyte proliferation, and cell migration during tumour invasiveness (Launay et al., 2005; Helfer et al., 2006) .
Various members of the caspase family, i.e caspases 1, 2, 3, 6, 7 and 12, have been shown to be expressed in mouse embryos (Exley et al., 1999) . Although blastomeres are susceptible to programmed cell death in unfavourable culture conditions, the ocurrence of apoptosis under physiological conditions is rare before implantation, suggesting that caspases could have non-lethal functions during preimplantation development (Pampfer et al., 1999) . Recenty, Zakeri et al., showed that the culture of mouse embryos with the generalized caspase inibitor zVAD did not only fail to prevent the death of ICM cells in culture but, conversely, disrupted the normal development of embryos to the blastocyst stage (Zakeri et al., 2005) .
Mouse preimplantation development is an attractive model to study events of early differentiation in mammalian cells. Mouse cultured embryos have a well-defined number of cells in a period that is consistent and relatively short, and develop independently of external factors (i.e. serum suplements) that frequetly interfere with analyses. Mammalian development begings with the successive cleavage of fertilized eggs into 2-cell, 4-cell and 8-cell embryos. The first morphologically distinguishable differentiation event in the dividing embryo is the compaction of cleaving blastomeres into a coherent mass of cells, the morula. The process of compaction starts at the 8-cell stage, and is a conseused with the aim of evaluating the relevance of caspase activitiy during mouse preimplantation embryo development and understanding the possible mechanisms of action of these proteases. The first objective was addressed by analyzing the effect of specific caspase inhibitors during mouse in vitro embryo development. The second goal was undertaken using an in silico approach by large-scale management of biological data obtained from mouse embryos and the prediction of putative caspase targets using bioinformatic tools. The evidence obtained in this work support the involvement of caspases in vital functions during mouse embryo preimplantation development, proposing a model where the cleavage of caspase substrates could account for these non-lethal roles.
Results
In an attempt to determine which caspase(s) were active in mouse preimplantation embryos, two-cell stage embryos were cultured with different caspase inhibitors and the progression of development was monitored daily. Our results showed that the general inhibition of caspases using zVAD affected early development of mouse embryos (Fig. 1) . Those embryos never reached the morula stage and remained arrested at the four-or the eightcell stage. Inhibitors for caspase 2 or 9 were inocuous at a 100 μM concentration, as embryos in those treatment underwent their 66,7 ± 33,3 (3) 80,0 ± 20,0 (3) 96,7 ± 3,3 (3) inh C9
46,7 ± 26,0 (3) 73,0 ± 13,6 (4) 78,8 ± 9,1 (5) inh C2 4,6 ± 2,9* (5) 77,4 ± 15,5 (5) 89,8 ± 8,8 (6) inh C8 52,0 ± 18,3 (4) 92,3 ± 4,5 (4) 87,8 ± 3,2 (5) DMSO 0,0 ± 0,0 (3) 2,7 ± 2,7* (3) 57,0 ± 16,6 (3) zVAD 81,0 ± 7,0 (4) 93,3 ± 4,2 (4) 92,0 ± 3,4 (5) control mean ± SE (n) mean ± SE (n) mean ± SE (n) treatment E4 E3 E2 E1 Fig. 1 . Development in the presence of caspase inhibitors. Two-cell embryos (E1) were incubated in medium alone (control), or containing either 1 μl DMSO or 1 μl of a stock solution (20 mM) of inhibitors for general caspase activity (zVAD), caspase 8 (inh C8), caspase 2 (inh C2) or caspase 9 (inh C9) dissolved in DMSO. The percentage ± ES of embryos that reached the expected developmental stage at day 2 (4-cell to 8-cell: E2), day 3 (morula: E3) and day 4 (blastocyst: E4) after the beginning of the experiment are indicated for each treatment. Significant values are shown on a gray background (*p≤ 0.05). The number of experiments (using 8-15 embryos/drop) is indicated between brackets. were observed under an inverted microscope, and the number of compacted morulae was determined. The percentage of compact embryos was significanly reduced in the presence of caspase 8 inhibitor compared to both controls, i.e. in the absense of inhibitor or with DMSO (*p≤ 0.05). (B,C) Immunoreactivity for tight junction protein ZO-1. Embryos were fixed, permeabilized and subjected to immunofluorescence using anti-ZO-1. (B) Noncompacted morulae lacked immunoreactivity for anti-ZO-1; (a) non-compacted morula lacking ZO-1; (b) partially compacted morula showing ZO-1 in some blastomeres only. (C) Blastocysts used in parallel as positive controls showed specific staining in trophoectoderm cell-cell contact regions. (Ziomek et al., 1980) and the formation of cell-cell adhesion structures such as adherens junctions (Shirayoshi et al., 1983; De Vries et al., 2004) , tight junctions (Sheth et al., 1997; Wang et al., 2008) and gap junctions (Houghton et al., 2005) . Compaction is followed by the formation of a central cavity, process known as cavitation, and the differentiation of two distinct cell types: the trophoectoderm and the inner cell mass (ICM), to form the blastocyst. A combination of in vitro and in silico approaches were developmental programme up to the blastocyst stage similarly to those in drops containing DMSO alone. Of the three specific caspase inhibitors included in this study, only caspase 8 inhibitor clearly arrested development. It was surprising to note that, differently to the results observed with zVAD, caspase 8 inhibitor did not affect the number of embryos reaching the morula stage, but reduced significantly the number of embryos progressing from the morula to the blastocyst stage.
In caspase 8 inhibitor-treated embryos, the morphology of morulae was different to that of morulae in control drops. While untreated embryos at E3 showed a mass of cohesive cells, characteristic of morulae that have undergone compaction, arrested embryos had mostly rounded blastomeres showing no morphological signs of compaction ( Fig. 2A) . The quantification of this effect indicated that the percentage of compact morulae was significantly reduced by caspase 8 inhibitor. In agreement with these observations, indirect immunoflouorescence experiments showed that caspase 8 inhibitor-treated morulae lacked the characteristic membrane localization of tight junction protein 1 (ZO-1), involved in the formation of tight juntions in the embryo at compaction (Fig. 2B a,b) (Sheth et al., 1997) . Confirming the specificity of our immunofluorescence experiments, embryos that had progressed to blastocyst and were incubated with anti-ZO-1 showed the characteristic staining, i.e present at the cell-cell contact region of trophoectoderm cells and absent in ICM cells (Fig. 2C) (Sheth et al., 1997) . At E3, when a defect in compaction was observed, there were no significant differences in the numNAs were detected in 4-cell embryos, morulae and blastocysts and not in oocytes or 2-cell embryos (Fig. 4B) . Thus, the expression pattern found for caspase 8 was in agreement with the timing of the effect observed for caspase-8 inhibition, as this only took place after the 8-cell stage.
Caspases extert their apoptotic function by cleaving a number of subtrates that lead to cell death. However, the mechanism of action of non-lethal caspase functions is less clear. Given the scarcity of the biological material that can be obtained from mammalian embryos, a database of expressed sequence tags (ESTs), published from high-throughput studies applied to mouse preimplantation embryos, was compiled using the mouse library browser from UniGene database so that a single library was DMSO inh C8 bers of cells in DMSO and caspase 8 inhibitor-treated embryos (Fig. 3) . The normal proliferation of 16 to 32-cell embryos in the presence of caspase 8 inhibitor suggests that this treatment did not affect the cell cycle progression until that stage. Control embyos in DMSO proliferated normally until the following day (E4), whereas caspase 8-treated embryos showed a significant decrease in the number of blastomeres. Although the expression and activity of some members of the caspase family in mouse embryos has already been demonstrated (Exley et al., 1999; Hinck et al., 2001; Hinck et al., 2003; Little et al., 2003) , to our knowledge this is the first report showing the presence of caspase 8. Both 4-cell embryos (results not shown) and morulae subjected to indirect immunofluorescence using anti-caspase 8 specific antibody showed strong fluorescent staining (Fig. 4A) . The absence of staining in embryos incubated with anti-caspase 3 or without primary antibody (results not shown) confirmed the specificity of the results. RT-PCR experiments confirmed the expression of caspase 8 in preimplantation embryos. Interestingly, caspase 8 mR- (Table 1) . Using UniGene identifiers, the associated direct protein products were extracted from the UniProt database (see Methods). Fig. 5 (Rogers et al., 1986; Rechsteiner et al., 1996; Garay-Malpartida et al., 2005) . The parsed list of caspase candidate targets for each preimplantational stage was functionally annotated by exploring Gene Ontology (GO) associations for mouse. The numbers of proteins with GO annotations were: 280 proteins for one-cell, 293 for two-cells, 229 for four-cells, 235 for eight-cells, 134 and 345 for morula and blastocyst, respectively (Fig. 5 ). In total, the nonredundant caspase substrates expressed along the preimplantation mouse embryos predicted by the bioinformatic approach were 510 proteins.
The functional annotation obtained by GO for the 510 putative caspase substrates in embryos indicated their association to diverse subcellular localizations, molecular functions and biological processes. Considering the results of our in vitro experiments using caspase inhibitor-treated embryos, special attention was paid to those proteins related to functions affected the inhibitors. As described previously, zVAD affected early events of development, related to blastomere proliferation, and caspase 8 inhibitor had an effect at later stages, where the processes of cell adhesion/communication and differentiation occur. The functional char- 36036  24509  16878  24502  11770  64803  5506  6217  3934  4200  2534  7612  4173  4705  3394  3388  2105  6034  2930  3341  2456  2401  1659  4484  280  293  229  235  134 
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acterization by GO of CasPredictor-identified caspase targets indicated that 9,8% of the sequences were related to the progress of the cell cycle, 6,5% to cell proliferation and 3,3% to cell division, while 24% of the sequences were related to cell communication, 6,7% to cell adhesion and around 2% to cell fate commitment or differentiation.
Recently, a database known as CASBAH (CAspase Substrate DataBAse) has been published, where all the proteins shown to be caspase substrates by biochemical methods are compiled (Luthi et al., 2007) . From a total of 412 CASBAH proteins, only 30 belong to mouse, 356 to human, another 13 to rat and the remaining 13 to other organisms. We used the Mouse Genome Informatics (MGI) database (Eppig et al., 2007) to achieve mouse CASBAH caspase substrates orthologous to human and rat, and then compared them to those obtained in mouse embryos by CasPredictor. This comparison showed that of a total of 510 proteins obtained as putative caspase substrates in mouse embryos by CasPredictor, 63 orthologous sequences were demonstrated in the literature to be caspase targets in other systems. Some interesting examples related to non-apoptotic functions are the cell divison control protein 6 (Cdc6) (Hateboer et al., 1998) , the negative regulator of mitosis wee1 (Wee1) (Honda et al., 1995) and geminin (Gmnn) (McGarry et al., 1998) involved in proliferation, Beta-catenin (Ctnnb1) (Xu et al., 2007) and presenilin (Psen1) (Georgakopoulos et al., 2000) related to cell adhesion and myeloid leukemia cell differentiation protein MCL-1 homolog (Mcl1) (Okita et al., 1998) , Beta-catenin (Xu et al., 2007) and Serum Response Factor (SRF) (Arsenian et al., 1998) with roles in differentiation.
As another approach to determine the possible participation of caspase activity for the progression of preimplantation development, the CasPredictor-derived substrates were compared to a list of proteins whose deficiency in knockout (KO) mouse models produces embryonic lethality before implantation (Eppig et al., 2007) . The result of this analysis showed that 11 out of the 108 embryo lethal knockout genes are transcribed into proteins that can be proteolytically cleaved by caspases. Fig. 6 lists these proteins showing the phenotype of their knockouts, and the GO functional assignation and stage where they are present. As shown, two of the embryo lethal KO genes that were identified as caspase substrates by CasPredictor, beta-catenin and geminin, were also found in the CASBAH database.
Discussion
Besides the traditional idea where caspase function executes apoptosis, recent evidence indicate that caspase activation does not systematically trigger cell death but can promote processes relevant for life (Abraham et al., 2004; Launay et al., 2005) . In this work, we have used mouse embryo development in vitro to evaluate vital roles of caspases. Several reasons have lead us to use this model. First, mouse embryo culture is a reproducible and efficient system. Starting from a embryo with a pair of morphologically identical blastomeres, after three days in culture in the absence of serum or growth factors, a more complex and differentiated entity, the blastocyst, forms in the culture dish. Second, although caspases and other molecules related to apoptosis have been shown to be present in embryos (Exley et al., 1999; Hinck et al., 2001; Hinck et al., 2003; Little et al., 2003) , significant levels of programmed cell death does not take place before implantation (Pampfer et al., 1999) , suggesting that those molecules might be involved in non-lethal processes. Third, the progression of an early embryo from the 2-cell stage to the blastocyst stage involves a series of observable events that occur in a cell-specific and timedependant manner.
The main biological processes occuring in the blastomeres are cell division or proliferation, cell adhesion or communication, at compaction, and cell differentiation to form two cell types in the blastocyst. As mentioned previously, caspase activities have been related to these processes in different somatic and cancer cells. In embryos, Zakeri et al., showed for the first time that a nonlethal caspase activity is present before implantation (Zakeri et al., 2005) . In agreement with those sudies, our results showed that the general caspase inhibitor zVAD significantly affected development, with 2-cell embryos showing an arrest at the 4-to 8-cell stage and thus never reaching the blastocyst stage. The effect of zVAD in early embryos, before compaction or differentiation take place, suggests that the main process affected is the proliferation of blastomeres. In an attempt to identify individual caspase activities required for the progression of development, 
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Fig. 6. Preimplantation lethal knockouts for caspase targets in embryos.
Protein name and ID, phenotype of the KO embryos, GO functional association of the protein and stage where the coding ESTs where found in expression libraries. * The asterisks indicate caspase targets previously described in other systems. Knockouts for proteins coloured pale blue are deficient in blastomere proliferation and proteins colored green have defects related to compaction and differentiation of throphoectoderm and inner cell mass.
inhibitors for the caspases 2, 8 and 9 were selected. All of these proteases are initiators of the caspase cascade, and are not directly responsible for the cleavage of substrates promoting cell death but have been previously related to events of differentiation (Launay et al., 2005) . The results of these experiments showed that caspase 2 and 9 activities were dispensable for embryo development. On the other hand, caspase 8 activity was important for the progression from the morula to the blastocyst stage. A clear effect on compaction was indicated by the morphological aspect of blastomeres and the absence of the tight junction protein ZO-1 in cell-cell contact areas. Caspase 8-treated embryos proliferated normally until the defect on compaction took place. Thus, the reduction in blastomere numbers observed later was probably due to the altered developmental program of noncompacted embryos rather than to an effect of the inhibitor on the cell cycle itself.
Caspase-8 knock mice do not show embryonic lethality before implantation, as null embryos can implant but die in utero due to defects attributable to circulatory failure (Varfolomeev et al., 1998; Sakamaki et al., 2002) . Although this evidence might seem contradictory with our results, the unaffected preimplantation development in those embryos might be due to compensation by other proteins. One clear example of this functional compensatory mechanism has been demonstrated in beta-catenin null mice, where protein plakoglobin can take over the function of beta-catenin during blastomere compaction (Huelsken et al., 2000) .
One curious observation of this work is that the effect of general inhibitor zVAD was earlier than that of caspase 8 inhibitor. An issue worth considering is that chemical inhibitors can produce unintended effects on other proteases with similar substrate specificities, i.e. Granzyme B and Cathepsin L (Thornberry et al., 1997; Schotte et al., 1999) . This side-inhibition could account for the additional effects of zVAD over caspase 8 inhibitor. A more interesting possibility is that other caspases besides caspase 8 are involved in early stages of embryo development.
In agreement with the effect of its inhibitor, caspase 8 was detected by immunofluorescence and RT-PCR in mouse embryos around the time of compaction. Although a deeper analysis is required to determine what processes or molecular pathways were inhibited in caspase 8-treated arrested morulae, our results suggest that, among other events, molecules involved in cell adhesion and cell differentiation are the most likely to be regulated by that caspase activity.
One of the disadvantages of the mouse embryo model is that the material available for protein analyses is scarse compared to that available using other cell types, or even embryos from other models (i.e. Xenopus or sea urchin). However, the existence of a growing inventory of mouse genes annotated in public databases, expressed in different developmental stages, can still be used to explain events taking place in embryos at the molecular level. In this work, a bioinformatic approach facilitated by large-scale management of biological data was used to evaluate the role of caspases in mouse preimplantation development. In the first place, the total mouse preimplantation embryo ESTs from different publications were compiled into a single library for each developmental stage. In general, the amount of EST sequences for the different stages was similar, near 20,000, with the exceptions of morula, with half that amount, and blastocyst, where a higher number of ESTs (more than 60,000) has been published. The difference in the amount of ESTs for each embryo stage is worth considering when quantitative comparisons are made from these data. The posterior crosstalk among sequence databases allowed the indentification of the cohort of the genes and protein products represented in the ESTs. The number of proteins predicted to be expressed in embryos was around 10% of the number of ESTs identified (range 7 to 14%, depending on the different stages). A large-scale analysis of those proteins using the CasPredictor software allowed the identification of feasible caspase cleavage sites present in those proteins. The functional assignation of these putative caspase substrates in embryos by GO indicated their involvement in a broad variety of biological processes in different cell types. Interestingly, for each of the developmental stages analyzed, an 8 to 10% of the expressed proteins with assigned functions were putative substrates for caspases, suggesting that these proteases could be involved in the regulation of numerous molecular pathways related to different processes, not only apoptosis, within the cell.
A list of 510 putative caspase substrates found in mouse preimplantation embryos was obtained by the bioinformatic procedures described above. The fact that near half of those caspase substrates are related to vital functions such as cell proliferation, communication or differentiation is in agreement with our results showing that the inhibition of caspase activity in mouse embryos affects the progression of embryo development. One interesting observation from our results is that many caspase substrates present in embryos belong to the Wnt signal transduction cascade, involved in numerous events of embryo development and in the control of homeostatic cell renewal in several adult tissues (Clevers et al., 2006; Harwood et al., 2008) . Some of these proteins are LRP6 and LRP1 co-receptors of Frizzled (Wnt Receptor), Axin and Daple, positive and negative regulators of Beta-catenin stabilization, Alpha-catenin, Beta-catenin, Deltacatenin and Lim-domain binding protein 1 (Ldb1). Only 63 of the 510 putative substrates were previously described in the literature as caspase targets. Whether the 447 remaining sequences are in fact physiological caspase substrates in embryos or other cell types is still to be determined. In this sense, the bioinformatic procedure undertaken in this work may be useful to provide substantial material for future investigations on the non-lethal role of caspases in mammalian cells.
Degradation of substrates
The relevance of caspase substrates for preimplantation development was also suggested by the preimplantation lethality described in knockout mice deficient for the coding genes of 11 of the putative caspase substrates identified in this work. In general, the phenotype of the KO embryos is in agreement with a deficiency in the function assigned by GO for each of the proteins. Deficiencies in caspase substrates involved in cell adhesion or differentiation in other cell types, produce an arrest at the morula stage, with defects in compaction and differentiation of TE and ICM cells, while deficiencies in proteins involved in proliferation produce in the embryo a failure to undergo the developmental program at earlier stages, when cell division seems to be the main process involved. It was surprising to note that in calpain-2 KO mice, embryos are arrested during early development while the presence of EST for calpain-2 is only detected past the morula stage. In that case, the heterogeneity in the source and the quantity of EST sequences available among different embryo stages may have limited the detection of calpain-2 in earlier embryos. Supporting our idea, Calpain-2 mRNAs have been detected by immunofluorescence (Raynaud et al., 2008) and RT-PCR (Dutt et al., 2006) in mouse embryos at the 8-cell stage, earlier than Calpain-2 ESTs, detected at the morula stage. As in the case of calpain, the limited amount of material from embryos is a caviot of our EST analyses that could affect the interpretation of results. However, in this work we have succeeded in identifying two proteins that are both essential for embryo development and caspase-proven substrates published in the CASBAH database: Beta-catenin and Geminin.
Although the mechanisms responsible for regulating the dual function of caspases in apoptosis and vital processes are unknown, the selective cleavage of specific substrates involved in cell death and life events could explain this duality (Fig. 7) . As well, despite the ortodox notion where caspase activation promotes the proteolytical degradation of target proteins, in some cases these proteases can induce the activation of proteins to promote non-lethal functions. One example of this activating function of caspases takes place during the differentiation of skeletal muscle, where the cleavage of a protein known as Mammalian Sterile Twenty-like Kinase (MST1) promotes differentiation of myoblasts (Fernando et al., 2002) . In a similar manner, the regulated cleavage of substrates could determine their involvement in one or another function. As an example, the cleavage of Beta-catenin could provide a mechanism regulating its involvement in signalling (canonical pathway) or cell adhesion (non-canonical). This might be specially relevant in embryos, where Beta catenin was recently shown to be an important molecule for blastomere compaction (Na et al., 2007) besides its well-known participation in the establishment of the three embryo layers shortly after implantation (De Vries et al., 2004) . There is also evidence indicating that Geminin, a multifunctional protein that dominates the balance between cell proliferation and differentiation, can be cleaved by caspases in two sites; the two resulting caspasecleavage forms interact with different regulators and, as a consequence, promote differential effects on the cell (Hara et al., 2006; Roukos et al., 2007) . Another possible mechanism explaining life giving caspase functions is the degradation of proteins that serve as inhibitors of cellular processes such as cell cycle or differentiation. In this case, caspases might cleave and inactivate cell cycle checkpoint proteins or inhibitors of reprogramming mechanisms that need to be removed for cells to reach their appropiate fate (i.e. cell division, cell differentiation). One example of this mechanism has been described in T-cells, where the cleavage of the cell cycle inhibitor Wee during caspase activation is correlated to proliferation (Zhou et al., 1998) . Interestingly, our results showed that protein Wee is expressed in mouse embryos before implantation (results not shown).
In summary, our results using a combination of experimental and bioinformatic approaches support the participation of caspases in the development of mouse preimplantation embryos, and allow us to propose a mechanism where these proteases can regulate the presence or activity of substrates involved in vital cell functions such as proliferation and differentiation. Alhough the involvement of caspases in both cell death and non-lethal functions is intriguing, it is probable that these proteins are players of a complex network of molecules acting in synchrony to regulate the number, differentiation state and survival of cells.
Materials & Methods
Animals
Young adult (30-60 days) female CF1 mice and adult (3-12 months) male mice of the same strain were used for the experiments described in this work. Animals were maintained at 23°C with a 12L:12D cycle. Experiments were conducted in accordance with the Guide for Care and Use of Laboratory Animals approved by the National Institute of Health (NIH) and the Biosafety Guide provided by the Chilean Research Council (CONICYT).
Embryo retrieval and treatment with caspase inhibitors
Mouse females were superovulated by an injection (i.p.) of 5 IU equine Chorionic Gonadotropin (eCG) (Sigma Chemical Co., St. Louis, MO) followed by the administration (i.p.) of 5 IU human Chorionic Gonadotropin (hCG) (Sigma) 48 hs later and caged with males overnight. Those females showing vaginal plugs, as an indicator of mating, were separated for the retrieval of embryos. The next day (E1) oviducts were placed under a dissecting microscope, and two-cell embryos were recovered in KSOM medium (Summers et al., 2000) , washed and placed in 200 μl drops of medium alone or containing 100 μM of caspase inhibitors (Calbiochem, San Diego, CA), under mineral oil (Sigma). The general caspase inhibitor Z-VAD-FMK, caspase 2 inhibitor Z-VDVAD-FMK, caspase 9 inhibitor Ac-AAVALLPAVLLALLAP-LEHD-CHO and caspase 8 inhibitor Ac-AAVALLPAVLLALLAP-IETD-CHO stocks were prepared at a 20 mM concentration in DMSO (Sigma) and diluted 1/200 in KSOM before use. Drops containing one microliter of DMSO alone were included in every experiment to discard an effect of the solvent per se. Treated and untreated embryos were cultured in a 37°C incubator with 5% CO 2 , and the progression of embryo development was monitored daily for the following 3 days (E2, E3, E4). Embryos at E3 were observed under an inverted microscope (Model CKXY1, Olympus Co., Japan) for the quantification of morulae compaction.
Indirect immunofluorescence (IIF) of mouse embryos
Embryos were fixed for 1 h in 0.2 ml of 4% paraformaldehyde in PBS at room temperature (RT), washed several times with PBS containing 4 mg/ml BSA (PBS-BSA4), and permeabilized by incubation for 1 h in 1% Triton X-100 in PBS at RT. After an incubation of 30 min at 37°C in blocking solution (1% BSA Glycine 130 mM in PBS) embryos were exposed for 1 h at 37°C to anti-ZO-1 (1/50 in blocking solution) (Zymed Laboratories, Invitrogen Co, Carlsbad, CA) or anti-caspase 8 antibody (US Biological, Swampscott, MA). Embryos in the absence of primary antibody were subjected to IIF in paralel as negative controls. After washing in PBS-BSA4, eggs were incubated for 30 min at 37°C in the appropriate FITC-conjugated secondary IgG (1:50 in PBS-BSA4, Sigma), washed, and finally mounted in VectaShield medium (Vector Laboratories, Burlingame, CA). Eggs were examined under phase contrast and fluorescence microscopy (Optiphot-2, Nikon, Japan). Pictures were acquired with a digital camera (CoolPix 4500, Nikon, Japan).
RT-PCR analysis of mouse embryos
RNA was extracted from 40-50 oocytes and embryos from each embryo stage: 2-cell, 4-cell, morulae and blastocysts using Trizol ® Reagent (Invitrogen Corp, Carlsbad, CA, US) using the protocol indicated by the manufacturer. RNAse-free glycogen (Invitrogen) (10 μg/tube) was added as carrier for the precipitation of small quantities of RNA. Reverse transcription was perfomed using Reverse Trancriptase from Promega (Madison, WI, US), and the resulting cDNA was used for PCR using Taq Polimerase (Invitrogen) as indicated by the manufacturer, for 40 cycles. Specific primers for caspase 8, designed based on public sequences obtained from GenBank (Wheeler et al., 2003) , were as follows: Sense 5' CAAGCACAGAGAGAAGAATG, Antisense 5' AGGTCTTACTCAGAGCCTC. As a control, caspase 8 was also amplified from liver cDNA equivalent to 1 μg RNA input, prepared as previously described. RT (-) reactions, corresponding to samples from liver and oocyte processed in parallel the absence of the RT enzyme, were completely negative. RT-PCR products were visualized in 1,5% agarose gels containing etidium bromide.
Compilation of EST libraries from mouse embryo preimplantation stages
In order to obtain the preeminent transcript data for Mus musculus the UniGene database Build #171 (Wheeler et al., 2003) was queried. UniGene is a comprehensible publically available database for mouse EST sequences, grouped in libraries according to the preimplantation stage where the transcripts belong (one-cell, two-cell, four-cell, eight-cell, morula and blastocyst). Using the library browser, data from each embryonic developmental stage were explored and downloaded. A merged sequence library resulted for each stage and the unique UniGene identifiers were filtered so that one UniGene ID represented several of these EST clustered to one expressed locus or transcript. The UniGene database was scanned with the aforementioned UniGene IDs to extract their relative gene IDs (the conversion table can be accessed from ftp:// ftp.ncbi.nih.gov/repository/UniGene/). Then, using these set of gene IDs, the UniProt database for Mus musculus was queried to obtain the associated protein present at each preimplantation stage.
Identification of putative caspase targets using CasPredictor software
Caspases are cysteine proteases that cleave substrates at specific tretapeptide sites (denoted as P 4 P 3 P 2 P 1 ) featured by remarkable specificity to aspartate (D) in P 1 position. In this work, CasPredictor (GarayMalpartida et al., 2005) was used to search sequence patterns of caspase cleavage sites along the Mus musculus UniProt protein database. CasPredictor is a bioinformatics tool which uses scored amino acid substitutions, residue frequency and similarity with PEST-like sequences to predict proteolytical cleavage sites in proteins with high accuracy (Rogers et al., 1986; Rechsteiner et al., 1996; Garay-Malpartida et al., 2005) . This algorithm allows searching, comparing and evaluating protein segments where an aspartate residue is found. For each library, UniProt protein identifiers found within the list of CasPredictor predicted sequences were declared probable caspase cleavage candidates.. The resulted list of candidate proteins for caspase cleavage was filtered using a threshold score higher than 0,6 value. The Gene Ontology Annotation database provides annotation for genes and genes products of over 50 species (Ashburner et al., 2000) . To address the biological question in the context of the preimplantation embryo process, Gene Ontology terms were extracted from proteins Caspredictor selected proteins; see GO Consortium (2000) . Those suspicious candidates were queried among the validated caspases target database CASBAH (Luthi et al., 2007) and the knockout mouse databases in MGI (Eppig et al., 2007) .
Statistical analyses
Results were expressed as mean values ± SEM for each series of experiments. Two-way Anova was used to analyze the significance of differences found between percentages of embryos reaching the expected developmental stage for each day in each treatment. One way Anova was used to analyze the significance of differences in compaction among morulae in control, DMSO or caspase-8 treated embryos, and in cell numbers between caspase 8 inhibitor-treated and DMSO-treated embryos. Bonferroni post-tests were used in both analyses to compare values among treatments. The tests were considered significant at p values <0.05.
